177 related articles for article (PubMed ID: 33352229)
1. Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases.
Liu H; Zhan X; Xu G; Wang Z; Li R; Wang Y; Qin Q; Shi W; Hou X; Yang R; Wang J; Xiao X; Bai Z
Pharmacol Res; 2021 Feb; 164():105384. PubMed ID: 33352229
[TBL] [Abstract][Full Text] [Related]
2. Icariside I specifically facilitates ATP or nigericin-induced NLRP3 inflammasome activation and causes idiosyncratic hepatotoxicity.
Gao Y; Xu G; Ma L; Shi W; Wang Z; Zhan X; Qin N; He T; Guo Y; Niu M; Wang J; Bai Z; Xiao X
Cell Commun Signal; 2021 Feb; 19(1):13. PubMed ID: 33573688
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC.
Zhao J; Liu H; Hong Z; Luo W; Mu W; Hou X; Xu G; Fang Z; Ren L; Liu T; Wen J; Shi W; Wei Z; Yang Y; Zou W; Zhao J; Xiao X; Bai Z; Zhan X
Mol Med; 2023 Jul; 29(1):84. PubMed ID: 37400760
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
[TBL] [Abstract][Full Text] [Related]
5. Enhanced IL-1β Release Following NLRP3 and AIM2 Inflammasome Stimulation Is Linked to mtROS in Airway Macrophages in Pulmonary Fibrosis.
Trachalaki A; Tsitoura E; Mastrodimou S; Invernizzi R; Vasarmidi E; Bibaki E; Tzanakis N; Molyneaux PL; Maher TM; Antoniou K
Front Immunol; 2021; 12():661811. PubMed ID: 34220810
[TBL] [Abstract][Full Text] [Related]
6. Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis.
Kaufmann B; Kui L; Reca A; Leszczynska A; Kim AD; Booshehri LM; Wree A; Friess H; Hartmann D; Broderick L; Hoffman HM; Feldstein AE
Cell Mol Gastroenterol Hepatol; 2022; 14(4):751-767. PubMed ID: 35787975
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
[TBL] [Abstract][Full Text] [Related]
8. Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages.
Yeon SH; Yang G; Lee HE; Lee JY
J Leukoc Biol; 2017 Jan; 101(1):205-215. PubMed ID: 27256568
[TBL] [Abstract][Full Text] [Related]
9. Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome.
Yang G; Jang JH; Kim SW; Han SH; Ma KH; Jang JK; Kang HC; Cho YY; Lee HS; Lee JY
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316419
[TBL] [Abstract][Full Text] [Related]
10. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90.
Xu G; Fu S; Zhan X; Wang Z; Zhang P; Shi W; Qin N; Chen Y; Wang C; Niu M; Guo Y; Wang J; Bai Z; Xiao X
JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33350984
[TBL] [Abstract][Full Text] [Related]
11. Glaucocalyxin A alleviates LPS-mediated septic shock and inflammation via inhibiting NLRP3 inflammasome activation.
Hou X; Xu G; Wang Z; Zhan X; Li H; Li R; Shi W; Wang C; Chen Y; Ai Y; Xiao X; Bai Z
Int Immunopharmacol; 2020 Apr; 81():106271. PubMed ID: 32062071
[TBL] [Abstract][Full Text] [Related]
12. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.
Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W
Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334
[TBL] [Abstract][Full Text] [Related]
13. [WP1130 relieves septic shock in mice by inhibiting NLRP3 inflammasome activation].
Lu L; Liu D; Yang Y; Wang F
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1747-1754. PubMed ID: 36651241
[TBL] [Abstract][Full Text] [Related]
14. [Isodopharicin C inhibits NLRP3 inflammasome activation and alleviates septic shock in mice].
Cao H; Zhang W; Li M; Yang Y; Li Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1476-1484. PubMed ID: 37814861
[TBL] [Abstract][Full Text] [Related]
15. 1'-Acetoxychavicol acetate inhibits NLRP3-dependent inflammasome activation via mitochondrial ROS suppression.
Sok SPM; Ori D; Wada A; Okude H; Kawasaki T; Momota M; Nagoor NH; Kawai T
Int Immunol; 2021 Jun; 33(7):373-386. PubMed ID: 33830232
[TBL] [Abstract][Full Text] [Related]
16. Carbamazepine promotes specific stimuli-induced NLRP3 inflammasome activation and causes idiosyncratic liver injury in mice.
Wang Z; Xu G; Zhan X; Liu Y; Gao Y; Chen N; Guo Y; Li R; He T; Song X; Niu M; Wang J; Bai Z; Xiao X
Arch Toxicol; 2019 Dec; 93(12):3585-3599. PubMed ID: 31677073
[TBL] [Abstract][Full Text] [Related]
17. C1q/tumour necrosis factor-related protein-9 aggravates lipopolysaccharide-induced inflammation via promoting NLRP3 inflammasome activation.
Xu D; Zhou X; Chen J; Li N; Ruan S; Zuo A; Lei S; Li L; Guo Y
Int Immunopharmacol; 2022 Mar; 104():108513. PubMed ID: 35008006
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release.
Pan J; Ou Z; Cai C; Li P; Gong J; Ruan XZ; He K
Cell Immunol; 2018 Oct; 332():111-120. PubMed ID: 30103942
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 Inflammasome and Caspase-1/11 Pathway Orchestrate Different Outcomes in the Host Protection Against
Paroli AF; Gonzalez PV; Díaz-Luján C; Onofrio LI; Arocena A; Cano RC; Carrera-Silva EA; Gea S
Front Immunol; 2018; 9():913. PubMed ID: 29774028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
